Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of remifentanil versus fentanyl for ICU analgesia
ChiCTR2400093424Phase 3Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of remifentanil in pain (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Pain relief success rate. Started Dec 2024; status: completed.
02
Drugs
remifentanil
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR2400093424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093424.